Skip to main content
Clinical Trials/EUCTR2010-023346-78-DK
EUCTR2010-023346-78-DKActive, not recruitingNot Applicable

Blod and urine concentrations of Procaterol in persons with asthma and elite athletes with asthma: a comparison of inhalation vs. oral administration.

Respiratory and Allergy research unit0 sites10 target enrollmentStarted: January 6, 2011Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
Male

Inclusion Criteria

  • - Sex: male
  • - Age: 18-40
  • - Informed consent
  • - No concurrent diseases (for the control group)
  • - Verified Asthma (for both normal asthma group and athlete group.)
  • - GINA 1-3
  • - used beta2-agonist for at least 12 months
  • - Practising sport on an elite niveau (more than 10 hours a week)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • - Smoker or former smoker with more than 10 years of smoking.
  • - Respiratory infektion within the last 2 weeks
  • - Other cronic ilness
  • - used beta2-agonist within 6 days of the study

Investigators

Sponsor
Respiratory and Allergy research unit

Similar Trials

Blod and urine concentrations of... | Clinical Trial